Search
Patexia Research
Case number 1:19-cv-00143

Pharmacyclics LLC et al v. Zydus Worldwide DMCC et al > Documents

Date Field Doc. No.Description (Pages)
May 11, 2021 N/A Terminated Case (0)
Docket Text: CASE CLOSED per the closing of Lead Case No. 18-192-CFC. (nmf)
May 3, 2019 N/A Create Case Association (0)
Docket Text: Case associated with lead case: Create association to 1:18-cv-00192-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-192-CFC ONLY. (nmf)
May 3, 2019 15 SO ORDERED (3)
Docket Text: SO ORDERED, re (149 in 1:18-cv-00192-CFC, 14 in 1:19-cv-00143-CFC) Joint STIPULATION for Consolidation. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-192-CFC ONLY. Signed by Judge Colm F. Connolly on 5/2/2019. Associated Cases: 1:18-cv-00192-CFC, 1:19-cv-00143-CFC(nmf)
May 1, 2019 14 Stipulation (3)
Docket Text: Joint STIPULATION for Consolidation by Janssen Biotech Inc., Pharmacyclics LLC. (Tigan, Jeremy)
Apr 12, 2019 13 Answer to Counterclaim (30)
Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim (Answer to Zydus's Counterclaims) by Janssen Biotech, Inc., Pharmacyclics LLC.(Tigan, Jeremy)
Apr 2, 2019 12 Order (1)
Docket Text: ORDER, this case having been recently joined and ready for scheduling pursuant to Fed. R.Civ. P. 16 and as this case is listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before May 1, 2019, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed.ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 5/1/2019.) Signed by Judge Colm F. Connolly on 4/2/2019. (nmf)
Mar 22, 2019 10 Answer to Complaint (30)
Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Janssen Biotech, Inc., Pharmacyclics LLC by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Moore, David)
Mar 22, 2019 11 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent none for Cadila Healthcare Limited; Corporate Parent Cadila Healthcare Limited for Zydus Worldwide DMCC filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Moore, David)
Mar 18, 2019 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [9] STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to March 22, 2019 filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Set/Reset Answer Deadlines: Cadila Healthcare Limited answer due 3/22/2019; Zydus Worldwide DMCC answer due 3/22/2019. Signed by Judge Colm F. Connolly on 3/18/2019. (fms)
Mar 15, 2019 9 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to March 22, 2019 - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu)
Feb 27, 2019 7 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Pharmacyclics LLC, Janssen Biotech, Inc.. Cadila Healthcare Limited served on 2/22/2019, answer due 3/15/2019. (Tigan, Jeremy)
Feb 27, 2019 8 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Pharmacyclics LLC, Janssen Biotech, Inc.. Zydus Worldwide DMCC served on 2/22/2019, answer due 3/15/2019. (Tigan, Jeremy)
Jan 30, 2019 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
Jan 28, 2019 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cadila Healthcare Limited on 1/28/2019; Zydus Worldwide DMCC on 1/28/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ddp)
Jan 25, 2019 1 Main Document (39)
Docket Text: COMPLAINT for Patent Infringement filed against Cadila Healthcare Limited, Zydus Worldwide DMCC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2553405.) - filed by Pharmacyclics LLC, Janssen Biotech, Inc.. (Attachments: # (1) Exhibit A-I, # (2) Exhibit J-O, # (3) Civil Cover Sheet)(ddp).
Jan 25, 2019 1 Exhibit A-I (661)
Jan 25, 2019 1 Exhibit J-O (466)
Jan 25, 2019 1 Civil Cover Sheet (1)
Jan 25, 2019 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ddp)
Jan 25, 2019 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/17/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 6/17/2021. (ddp)
Jan 25, 2019 4 Patent/Trademark Report to Commissioner (2)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s)- See Attached. (ddp)
Jan 25, 2019 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Pharmacyclics LLC filed by Janssen Biotech, Inc., Pharmacyclics LLC. (ddp).
Jan 25, 2019 6 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Biotech, Inc. filed by Janssen Biotech, Inc., Pharmacyclics LLC. (ddp)
Jan 25, 2019 1 Complaint* (1)
Menu